Insulet | PODD - PE价格收益



金融业
股票价格
USD
资产
USD 3.17B
现金及等价物
USD 534.9M
销售成本
USD 239.1M
流动资产
USD 1.85B
流动负债
USD 744.2M
债务
USD 948.4M
EBIT
USD 129.7M
EBITDA
USD 199.8M
员工
3.9K
EPS每股收益
USD 1.66
股本和储备
USD 1.42B
销售毛利
USD 562.6M
债务利息支出
USD 11M
利息收入
USD 4.9M
贷款资金
USD 929.5M
市值
USD 9.32B
净收入
USD 95M
营业费用
USD 672M
营业利润
USD 129.7M
普通股股本
USD 69.35M
PE价格收益
29.66
税前利润
USD 118.7M
销售收入
USD 801.7M
销售和管理费用
USD 344.8M
股票
USD 484.8M
贸易债权人
USD 123.3M
应收帐款人
USD 588.7M


Pe 更改 日
Abbott 23.85 1.08 2026-06
Align Technology 21.8 0.98 2026-06
AtriCure 129.01 94.86 2026-06
Baxter International 151.95 65.95 2026-06
Becton, Dickinson and Co. 17.68 114.67 2025-12
Boston Scientific 17.86 14.49 2026-06
Cardinal Health 30.4 5.87 2026-03
Cooper Companies 23.27 16.99 2026-03
Dexcom 24.61 0.12 2026-06
Edwards Lifesciences 30.77 3.9 2026-06
Eli Lilly 32.9 7.37 2026-06
Globus Medical 35.3 10.24 2026-03
ICU Medical 158.3 38.83 2025-12
Inogen 69.33 30.67 2021-09
Insulet 29.66 9.17 2026-06
Integra LifeSciences 10.28 5.21 2026-06
J&J 29.43 4.9 2026-06
Medtronic 19.66 3.1 2026-03
Merit Medical Systems 32.36 12.84 2026-03
Roche Holding 16.48 0.39 2026-06
Solventum Corp 43.68 145.42 2026-06
Stryker 27.46 2.98 2026-06
Tandem Diabetes Care 681.05 189.32 2022-03
Teleflex 49.25 21.46 2026-03
West Pharmaceutical Services 42.63 10.64 2026-06
Zimmer Biomet Holdings 17.33 8.14 2026-06